Net Income - Portage Biotech Inc (NASDAQ:PRTG) - Alpha Spread

Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 10.21 USD 3.03% Market Closed
Market Cap: 214.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Portage Biotech Inc
Net Income Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Net Income
-$71.1m
CAGR 3-Years
-53%
CAGR 5-Years
-68%
CAGR 10-Years
-35%
Theratechnologies Inc
TSX:TH
Net Income
-$7m
CAGR 3-Years
34%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Repare Therapeutics Inc
NASDAQ:RPTX
Net Income
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Net Income
-$50.4m
CAGR 3-Years
30%
CAGR 5-Years
4%
CAGR 10-Years
-12%
Covalon Technologies Ltd
XTSX:COV
Net Income
-CA$823.4k
CAGR 3-Years
25%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Net Income
-CA$18.5m
CAGR 3-Years
-33%
CAGR 5-Years
-51%
CAGR 10-Years
-5%

See Also

What is Portage Biotech Inc's Net Income?
Net Income
-71.1m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Net Income amounts to -71.1m USD.

What is Portage Biotech Inc's Net Income growth rate?
Net Income CAGR 10Y
-35%

Over the last year, the Net Income growth was 35%. The average annual Net Income growth rates for Portage Biotech Inc have been -53% over the past three years , -68% over the past five years , and -35% over the past ten years .

Back to Top